Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769780 · ClinicalTrials.gov registry record
A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy
A clinical trial, sponsored by Jazz Pharmaceuticals.
- Completed
- Registry status
- 1,500
- Enrollment target
NCT02769780: Completed study, sponsored by Jazz Pharmaceuticals.
NCT02769780 is a clinical trial that has completed, run by Jazz Pharmaceuticals. The registered enrollment target is 1,500 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02769780 has completed, sponsored by Jazz Pharmaceuticals.
- COMPLETED
- Registry status
- 1,500 participants
- Enrollment target
Study Summary
Nexus is a collaboration between academic institutions, advocacy and industry to answer important questions about narcolepsy. It is a web-based observational study of patient-reported outcomes in adult patients with narcolepsy, with follow-up every six months. Nexus website: www.narcolepsyregistry.com
Primary Outcome
Assessments include disease/diagnosis characteristics, disease/symptom characteristics, health-related quality of life (HRQoL), functioning, work productivity, resource utilization, and comorbidity burden at the time of enrollment and their progression through the course of the study
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,500 participants |
| Start Date | 2015-07-08 |
| Est. Completion | 2021-08-09 |
What the finished NCT02769780 record still lists
NCT02769780 is an observational study that tracks outcomes without assigning an intervention. Its 1,500 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT02769780 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02769780 about?
NCT02769780 is a clinical study titled "A Web-based Observational Study of Patient-reported Outcomes in Adults With Narcolepsy". Nexus is a collaboration between academic institutions, advocacy and industry to answer important questions about narcolepsy. It is a web-based observational study of patient-reported outcomes in adult patients with narcolepsy, with follow-up every six months. Nexus website: www.narcolepsyregistry....
What is the current status of trial NCT02769780?
This trial is currently completed. The enrollment target is 1,500 participants. The study started on 2015-07-08. Estimated completion is 2021-08-09.
Who is sponsoring clinical trial NCT02769780?
This trial is sponsored by Jazz Pharmaceuticals, which has 128 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00178724 · 1,500 participants
Spinal Cord Injury Registry - North American Clinical Trials Network
- NCT00951366 · 1,500 participants
Preterm Lung Patient Registry
- NCT01050504 · 1,500 participants
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
- NCT02071134 · 1,500 participants
Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI